Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
72 | DARU, Journal of Pharmaceutical Sciences | journal | 0.102 Q4 | 58 | 19 | 9 | 333 | 0 | 9 | 0.00 | 17.53 | |
71 | Journal of Applied Therapeutic Research | journal | 0.117 Q4 | 8 | 0 | 51 | 0 | 3 | 51 | 0.04 | 0.00 | |
70 | Pharmacy in Practice | journal | 0.119 Q4 | 6 | 25 | 70 | 141 | 5 | 40 | 0.08 | 5.64 | |
69 | Pharmaceutical Medicine | journal | 0.142 Q4 | 25 | 60 | 196 | 684 | 44 | 129 | 0.24 | 11.40 | |
68 | IDrugs : the investigational drugs journal | journal | 0.159 Q3 | 39 | 54 | 310 | 4189 | 71 | 306 | 0.21 | 77.57 | |
67 | Journal of Clinical Research | journal | 0.161 Q3 | 12 | 10 | 56 | 233 | 17 | 56 | 0.25 | 23.30 | |
66 | Pharmacology Reviews and Communications | journal | 0.165 Q3 | 9 | 26 | 43 | 777 | 15 | 43 | 0.24 | 29.88 | |
65 | Drugs in R and D | journal | 0.170 Q3 | 54 | 0 | 240 | 0 | 76 | 240 | 0.32 | 0.00 | |
64 | Pharmacology and Toxicology, Supplement | journal | 0.179 Q3 | 7 | 0 | 47 | 0 | 16 | 46 | 0.27 | 0.00 | |
63 | Paediatric and Perinatal Drug Therapy | journal | 0.183 Q3 | 20 | 18 | 38 | 381 | 15 | 34 | 0.41 | 21.17 | |
62 | Current Opinion in Investigational Drugs | journal | 0.185 Q3 | 83 | 36 | 0 | 1888 | 0 | 0 | 0.00 | 52.44 | |
61 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.220 Q3 | 5 | 0 | 35 | 0 | 15 | 30 | 0.43 | 0.00 | |
60 | Pharmacy and Pharmacology Communications | journal | 0.225 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
59 | Pharmaceutical Journal | journal | 0.232 Q3 | 28 | 901 | 1036 | 1740 | 114 | 480 | 0.11 | 1.93 | |
58 | Expert Opinion on Emerging Drugs | journal | 0.233 Q3 | 54 | 23 | 70 | 2173 | 60 | 68 | 0.89 | 94.48 | |
57 | BioDrugs | journal | 0.237 Q3 | 79 | 70 | 230 | 4783 | 142 | 218 | 0.58 | 68.33 | |
56 | Expert Opinion on Therapeutic Targets | journal | 0.254 Q3 | 106 | 47 | 135 | 5636 | 70 | 135 | 0.75 | 119.91 | |
55 | Mathematical Medicine and Biology | journal | 0.260 Q3 | 49 | 19 | 64 | 472 | 38 | 64 | 0.41 | 24.84 | |
54 | Reviews in Contemporary Pharmacotherapy | journal | 0.261 Q3 | 18 | 6 | 79 | 1445 | 107 | 79 | 2.28 | 240.83 | |
53 | Journal of Pharmacy and Pharmacology | journal | 0.264 Q3 | 137 | 213 | 1792 | 6060 | 1028 | 1758 | 0.55 | 28.45 | |
52 | ChemMedChem | journal | 0.273 | 119 | 157 | 351 | 2845 | 250 | 348 | 0.75 | 18.12 | |
51 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.275 Q3 | 25 | 21 | 54 | 738 | 52 | 28 | 0.93 | 35.14 | |
50 | Acta Pharmacologica Sinica | journal | 0.294 Q3 | 117 | 207 | 589 | 3661 | 357 | 588 | 0.67 | 17.69 | |
49 | Pharmaceutical Biology | journal | 0.297 Q3 | 88 | 97 | 232 | 2172 | 93 | 229 | 0.35 | 22.39 | |
48 | Biopharmaceutics and Drug Disposition | journal | 0.299 Q3 | 65 | 36 | 183 | 1661 | 147 | 181 | 0.86 | 46.14 | |
47 | Expert Opinion on Pharmacotherapy | journal | 0.301 Q3 | 93 | 168 | 105 | 11843 | 123 | 104 | 1.17 | 70.49 | |
46 | Tumor Targeting | journal | 0.357 Q2 | 10 | 0 | 54 | 0 | 62 | 52 | 1.44 | 0.00 | |
45 | Autonomic and Autacoid Pharmacology | journal | 0.376 Q2 | 24 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
44 | Fundamental and Clinical Pharmacology | journal | 0.379 Q2 | 85 | 52 | 219 | 1599 | 260 | 215 | 1.08 | 30.75 | |
43 | Phytotherapy Research | journal | 0.382 Q2 | 158 | 150 | 491 | 3332 | 358 | 489 | 0.79 | 22.21 | |
42 | Expert Opinion on Therapeutic Patents | journal | 0.404 Q2 | 88 | 126 | 429 | 6674 | 437 | 424 | 1.02 | 52.97 | |
41 | Current Opinion in Molecular Therapeutics | journal | 0.405 Q2 | 67 | 82 | 183 | 3634 | 214 | 170 | 1.17 | 44.32 | |
40 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.414 Q2 | 92 | 52 | 112 | 1639 | 150 | 112 | 1.23 | 31.52 | |
39 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.416 Q2 | 57 | 43 | 110 | 1572 | 89 | 102 | 0.94 | 36.56 | |
38 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.423 Q2 | 67 | 70 | 187 | 1684 | 140 | 186 | 0.77 | 24.06 | |
37 | Journal of Chemotherapy | journal | 0.428 Q2 | 56 | 150 | 295 | 4474 | 372 | 283 | 1.32 | 29.83 | |
36 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.429 Q2 | 81 | 63 | 186 | 1888 | 245 | 169 | 1.39 | 29.97 | |
35 | International Antiviral News | journal | 0.448 Q2 | 8 | 25 | 84 | 313 | 62 | 54 | 1.00 | 12.52 | |
34 | Immunopharmacology and Immunotoxicology | journal | 0.449 Q2 | 61 | 53 | 137 | 1624 | 170 | 137 | 1.18 | 30.64 | |
33 | International Journal of Neuropsychopharmacology | journal | 0.490 Q2 | 125 | 50 | 113 | 2485 | 150 | 110 | 1.34 | 49.70 | |
32 | Expert Opinion on Investigational Drugs | journal | 0.521 Q2 | 117 | 357 | 580 | 22450 | 915 | 575 | 1.72 | 62.89 | |
31 | Journal of Asian Natural Products Research | journal | 0.542 Q2 | 51 | 47 | 83 | 416 | 53 | 83 | 0.60 | 8.85 | |
30 | Antiviral Chemistry and Chemotherapy | journal | 0.547 Q2 | 59 | 37 | 121 | 1504 | 220 | 121 | 1.91 | 40.65 | |
29 | Cytokines, Cellular and Molecular Therapy | journal | 0.549 Q2 | 28 | 0 | 84 | 0 | 127 | 84 | 1.16 | 0.00 | |
28 | Xenobiotica | journal | 0.557 Q2 | 89 | 63 | 275 | 2378 | 561 | 274 | 1.95 | 37.75 | |
27 | Current Opinion in Drug Discovery and Development | journal | 0.561 Q2 | 85 | 82 | 160 | 3724 | 306 | 152 | 1.83 | 45.41 | |
26 | Biomedical Chromatography | journal | 0.571 Q2 | 71 | 79 | 310 | 2031 | 318 | 309 | 1.00 | 25.71 | |
25 | Journal of Peptide Science | journal | 0.571 Q2 | 73 | 66 | 166 | 2222 | 233 | 162 | 1.48 | 33.67 | |
24 | Pharmacogenomics | journal | 0.616 Q2 | 100 | 40 | 35 | 2061 | 66 | 35 | 1.89 | 51.53 | |
23 | Drug Discovery Today | journal | 0.638 Q2 | 215 | 362 | 633 | 5948 | 1063 | 577 | 1.71 | 16.43 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®